Skip to content

The Oncology Institute, Inc. TOI Weighted-Average Discount Rate

Weighted-Average Discount Rate at other companies

Belden logo
BeldenBDC
4.8%-0.1pp
Bioventus logo
BioventusBVS
8.1%0.0pp
Open Text logo
Open TextOTEX
5.3%0.0pp
CNB Financial logo
CNB FinancialCCNE
5.3%0.0pp
Aebi Schmidt Holding AG Common Stock logo
Aebi Schmidt Holding AG Common StockAEBI
3.9%+1.8pp
AZZ logo
AZZAZZ
6.6%-0.3pp

Other financials

Income statement

See full
Revenue$147.4M+41.2%
Operating income-$6.5M+34.3%
Net income-$2.5M+87.3%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$30.3M-23.8%
Total debt$104.9M+2.5%
Total equity-$16.3M-421%
Total assets$168.2M+2.6%

Cash flow

See full
Operating cash flow-$2.2M+55.6%
CapEx$1.0M+218%
Free cash flow-$3.3M+38.7%

Valuation

See full
Market cap$511.91M+133%
Enterprise value$586.58M+108%
P/S0.9×+0.4×

Profitability

See full
Operating margin-6%-2.1pp
Net margin-8%-2.7pp
FCF margin-5.1%

Returns & leverage

See full
Return on equity-277.6%-700pp
Debt / equity20.2×+17.3×
Current ratio1.5×-0.3×

Where this comes from

Reported directly by The Oncology Institute, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent.

The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Oncology Institute, Inc.'s weighted-average discount rate.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Oncology Institute, Inc.'s weighted-average discount rate?
The Oncology Institute, Inc. (TOI) reported weighted-average discount rate of 6.7% in Q1 2026.
How has The Oncology Institute, Inc.'s weighted-average discount rate changed year-over-year?
The Oncology Institute, Inc.'s weighted-average discount rate increased by 0.4% year-over-year, from 6.7% to 6.7%.
What does weighted-average discount rate mean?
This represents the average interest rate used to calculate the present value of the company's lease liabilities. It reflects the company's incremental borrowing rate or the rate implicit in the leases. This metric is essential for understanding the cost of capital embedded in the company's off-balance-sheet financing arrangements.